ID   PLPP1_RAT               Reviewed;         282 AA.
AC   O08564; Q8K594;
DT   15-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   29-MAY-2024, entry version 131.
DE   RecName: Full=Phospholipid phosphatase 1 {ECO:0000305};
DE            EC=3.1.3.- {ECO:0000269|PubMed:10359651, ECO:0000269|PubMed:8663293};
DE            EC=3.1.3.106 {ECO:0000250|UniProtKB:Q61469};
DE            EC=3.1.3.4 {ECO:0000269|PubMed:10359651, ECO:0000269|PubMed:8663293};
DE            EC=3.6.1.75 {ECO:0000269|PubMed:10359651};
DE   AltName: Full=Lipid phosphate phosphohydrolase 1;
DE   AltName: Full=PAP2-alpha;
DE   AltName: Full=Phosphatidate phosphohydrolase type 2a;
DE   AltName: Full=Phosphatidic acid phosphatase 2a;
DE            Short=PAP-2a;
DE            Short=PAP2a;
GN   Name=Plpp1 {ECO:0000312|RGD:621832}; Synonyms=Lpp1, Ppap2a;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   SUBSTRATE SPECIFICITY, ACTIVITY REGULATION, AND PATHWAY.
RC   TISSUE=Liver;
RX   PubMed=10359651; DOI=10.1042/bj3400677;
RA   Jasinska R., Zhang Q.-X., Pilquil C., Singh I., Xu J., Dewald J.,
RA   Dillon D.A., Berthiaume L.G., Carman G.M., Waggoner D.W., Brindley D.N.;
RT   "Lipid phosphate phosphohydrolase-1 degrades exogenous glycerolipid and
RT   sphingolipid phosphate esters.";
RL   Biochem. J. 340:677-686(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   STRAIN=Sprague-Dawley; TISSUE=Lung;
RX   PubMed=11704545; DOI=10.1152/ajplung.2001.281.6.l1484;
RA   Nanjundan M., Possmayer F.;
RT   "Molecular cloning and expression of pulmonary lipid phosphate
RT   phosphohydrolases.";
RL   Am. J. Physiol. 281:L1484-L1493(2001).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, ACTIVITY REGULATION,
RP   BIOPHYSICOCHEMICAL PROPERTIES, PATHWAY, AND SUBCELLULAR LOCATION.
RX   PubMed=8663293; DOI=10.1074/jbc.271.28.16506;
RA   Waggoner D.W., Gomez-Munoz A., Dewald J., Brindley D.N.;
RT   "Phosphatidate phosphohydrolase catalyzes the hydrolysis of ceramide 1-
RT   phosphate, lysophosphatidate, and sphingosine 1-phosphate.";
RL   J. Biol. Chem. 271:16506-16509(1996).
RN   [4]
RP   FUNCTION.
RX   PubMed=17057224; DOI=10.1074/jbc.m601670200;
RA   Pilquil C., Dewald J., Cherney A., Gorshkova I., Tigyi G., English D.,
RA   Natarajan V., Brindley D.N.;
RT   "Lipid phosphate phosphatase-1 regulates lysophosphatidate-induced
RT   fibroblast migration by controlling phospholipase D2-dependent
RT   phosphatidate generation.";
RL   J. Biol. Chem. 281:38418-38429(2006).
CC   -!- FUNCTION: Magnesium-independent phospholipid phosphatase of the plasma
CC       membrane that catalyzes the dephosphorylation of a variety of
CC       glycerolipid and sphingolipid phosphate esters including
CC       phosphatidate/PA, lysophosphatidate/LPA, diacylglycerol
CC       pyrophosphate/DGPP, sphingosine 1-phosphate/S1P and ceramide 1-
CC       phosphate/C1P (PubMed:10359651, PubMed:8663293). Also acts on N-oleoyl
CC       ethanolamine phosphate/N-(9Z-octadecenoyl)-ethanolamine phosphate, a
CC       potential physiological compound (By similarity). Through its
CC       extracellular phosphatase activity allows both the hydrolysis and the
CC       cellular uptake of these bioactive lipid mediators from the milieu,
CC       regulating signal transduction in different cellular processes
CC       (PubMed:10359651). It is for instance essential for the extracellular
CC       hydrolysis of S1P and subsequent conversion into intracellular S1P (By
CC       similarity). Involved in the regulation of inflammation, platelets
CC       activation, cell proliferation and migration among other processes (By
CC       similarity). May also have an intracellular activity to regulate
CC       phospholipid-mediated signaling pathways (PubMed:17057224).
CC       {ECO:0000250|UniProtKB:O14494, ECO:0000269|PubMed:10359651,
CC       ECO:0000269|PubMed:17057224, ECO:0000269|PubMed:8663293}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphate + H2O = a 1,2-diacyl-sn-
CC         glycerol + phosphate; Xref=Rhea:RHEA:27429, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:17815, ChEBI:CHEBI:43474, ChEBI:CHEBI:58608; EC=3.1.3.4;
CC         Evidence={ECO:0000269|PubMed:10359651, ECO:0000269|PubMed:8663293};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:27430;
CC         Evidence={ECO:0000305|PubMed:10359651};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-dihexadecanoyl-sn-glycero-3-phosphate + H2O = 1,2-
CC         dihexadecanoyl-sn-glycerol + phosphate; Xref=Rhea:RHEA:43236,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:72859,
CC         ChEBI:CHEBI:82929; Evidence={ECO:0000250|UniProtKB:O14494};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43237;
CC         Evidence={ECO:0000250|UniProtKB:O14494};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphate + H2O = 1,2-
CC         di-(9Z-octadecenoyl)-sn-glycerol + phosphate; Xref=Rhea:RHEA:43244,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:52333,
CC         ChEBI:CHEBI:74546; Evidence={ECO:0000269|PubMed:8663293};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43245;
CC         Evidence={ECO:0000305|PubMed:8663293};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + monoacyl-sn-glycero-3-phosphate = a monoacylglycerol +
CC         phosphate; Xref=Rhea:RHEA:46736, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:17408, ChEBI:CHEBI:43474, ChEBI:CHEBI:77589;
CC         Evidence={ECO:0000269|PubMed:10359651, ECO:0000269|PubMed:8663293};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46737;
CC         Evidence={ECO:0000269|PubMed:10359651};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-sn-glycero-3-phosphate + H2O = (9Z-
CC         octadecenoyl)-glycerol + phosphate; Xref=Rhea:RHEA:50884,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:75937,
CC         ChEBI:CHEBI:84973; Evidence={ECO:0000269|PubMed:8663293};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50885;
CC         Evidence={ECO:0000305|PubMed:8663293};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phosphate + H2O = a 1-acyl-sn-glycerol +
CC         phosphate; Xref=Rhea:RHEA:33155, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:57970, ChEBI:CHEBI:64683;
CC         EC=3.1.3.106; Evidence={ECO:0000269|PubMed:8663293};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33156;
CC         Evidence={ECO:0000305|PubMed:8663293};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(9Z-octadecenoyl)-sn-glycero-3-phosphate + H2O = 1-(9Z-
CC         octadecenoyl)-sn-glycerol + phosphate; Xref=Rhea:RHEA:39835,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:74544,
CC         ChEBI:CHEBI:75757; Evidence={ECO:0000250|UniProtKB:Q61469};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:39836;
CC         Evidence={ECO:0000250|UniProtKB:Q61469};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycerol 3-diphosphate + H2O = a 1,2-diacyl-
CC         sn-glycero-3-phosphate + H(+) + phosphate; Xref=Rhea:RHEA:27449,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:58608, ChEBI:CHEBI:59996; EC=3.6.1.75;
CC         Evidence={ECO:0000269|PubMed:10359651};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:27450;
CC         Evidence={ECO:0000305|PubMed:10359651};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + sphing-4-enine 1-phosphate = phosphate + sphing-4-enine;
CC         Xref=Rhea:RHEA:27518, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:57756, ChEBI:CHEBI:60119;
CC         Evidence={ECO:0000269|PubMed:10359651, ECO:0000269|PubMed:8663293};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:27519;
CC         Evidence={ECO:0000305|PubMed:10359651};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an N-acylsphing-4-enine 1-phosphate + H2O = an N-acylsphing-4-
CC         enine + phosphate; Xref=Rhea:RHEA:33743, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:52639, ChEBI:CHEBI:57674;
CC         Evidence={ECO:0000269|PubMed:10359651, ECO:0000269|PubMed:8663293};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33744;
CC         Evidence={ECO:0000305|PubMed:10359651};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-(octanoyl)-sphing-4-enine-1-phosphate = N-
CC         octanoylsphing-4-enine + phosphate; Xref=Rhea:RHEA:62040,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:45815,
CC         ChEBI:CHEBI:85376; Evidence={ECO:0000250|UniProtKB:O14494};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:62041;
CC         Evidence={ECO:0000250|UniProtKB:O14494};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-(9Z-octadecenoyl)-ethanolamine phosphate = N-(9Z-
CC         octadecenoyl) ethanolamine + phosphate; Xref=Rhea:RHEA:62160,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:71466,
CC         ChEBI:CHEBI:145465; Evidence={ECO:0000250|UniProtKB:O14494};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:62161;
CC         Evidence={ECO:0000250|UniProtKB:O14494};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphate +
CC         H2O = 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycerol + phosphate;
CC         Xref=Rhea:RHEA:41255, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:64839, ChEBI:CHEBI:75466;
CC         Evidence={ECO:0000269|PubMed:10359651};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41256;
CC         Evidence={ECO:0000305|PubMed:10359651};
CC   -!- ACTIVITY REGULATION: Magnesium-independent phospholipid phosphatase
CC       (PubMed:10359651, PubMed:8663293). Insensitive to N-ethylmaleimide
CC       (PubMed:10359651). {ECO:0000269|PubMed:10359651,
CC       ECO:0000269|PubMed:8663293}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=3.5 uM for 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphate (at pH
CC         6.5 and 37 degrees Celsius) {ECO:0000269|PubMed:8663293};
CC         KM=0.4 uM for (9Z)-octadecenoyl-sn-glycero-3-phosphate (at pH 6.5 and
CC         37 degrees Celsius) {ECO:0000269|PubMed:8663293};
CC         KM=1.9 uM for N-acylsphing-4-enine 1-phosphate (at pH 6.5 and 37
CC         degrees Celsius) {ECO:0000269|PubMed:8663293};
CC         KM=4.0 uM for sphing-4-enine 1-phosphate (at pH 6.5 and 37 degrees
CC         Celsius) {ECO:0000269|PubMed:8663293};
CC         Vmax=0.55 umol/min/mg enzyme with 1,2-di-(9Z-octadecenoyl)-sn-
CC         glycero-3-phosphate as substrate {ECO:0000269|PubMed:8663293};
CC         Vmax=0.19 umol/min/mg enzyme with (9Z)-octadecenoyl-sn-glycero-3-
CC         phosphate as substrate {ECO:0000269|PubMed:8663293};
CC         Vmax=0.26 umol/min/mg enzyme with N-acylsphing-4-enine 1-phosphate as
CC         substrate {ECO:0000269|PubMed:8663293};
CC         Vmax=0.15 umol/min/mg enzyme with sphing-4-enine 1-phosphate as
CC         substrate {ECO:0000269|PubMed:8663293};
CC   -!- PATHWAY: Lipid metabolism; phospholipid metabolism.
CC       {ECO:0000269|PubMed:10359651, ECO:0000269|PubMed:8663293}.
CC   -!- SUBUNIT: Forms functional homodimers and homooligomers that are not
CC       required for substrate recognition and catalytic activity (By
CC       similarity). Can also form heterooligomers with PLPP2 and PLPP3 (By
CC       similarity). {ECO:0000250|UniProtKB:O88956,
CC       ECO:0000250|UniProtKB:Q61469}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:8663293};
CC       Multi-pass membrane protein {ECO:0000255}. Apical cell membrane
CC       {ECO:0000250|UniProtKB:O14494}; Multi-pass membrane protein
CC       {ECO:0000255}. Membrane raft {ECO:0000250|UniProtKB:O14494}; Multi-pass
CC       membrane protein {ECO:0000255}. Membrane, caveola
CC       {ECO:0000250|UniProtKB:Q61469}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=O08564-1; Sequence=Displayed;
CC       Name=2; Synonyms=LPP1a;
CC         IsoId=O08564-2; Sequence=VSP_009653;
CC   -!- PTM: N-glycosylated. N-linked sugars are of the complex type. N-
CC       glycosylation is not required for the phosphatase activity.
CC       {ECO:0000250|UniProtKB:Q61469}.
CC   -!- SIMILARITY: Belongs to the PA-phosphatase related phosphoesterase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U90556; AAB50246.1; -; mRNA.
DR   EMBL; AF503609; AAM28631.1; -; mRNA.
DR   AlphaFoldDB; O08564; -.
DR   STRING; 10116.ENSRNOP00000062843; -.
DR   SwissLipids; SLP:000000610; -.
DR   GlyCosmos; O08564; 1 site, No reported glycans.
DR   GlyGen; O08564; 1 site.
DR   iPTMnet; O08564; -.
DR   PhosphoSitePlus; O08564; -.
DR   PaxDb; 10116-ENSRNOP00000062843; -.
DR   AGR; RGD:621832; -.
DR   RGD; 621832; Plpp1.
DR   eggNOG; KOG3030; Eukaryota.
DR   InParanoid; O08564; -.
DR   PhylomeDB; O08564; -.
DR   Reactome; R-RNO-9845614; Sphingolipid catabolism.
DR   UniPathway; UPA00085; -.
DR   PRO; PR:O08564; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016324; C:apical plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005901; C:caveola; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0106235; F:ceramide-1-phosphate phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0000810; F:diacylglycerol diphosphate phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0042577; F:lipid phosphatase activity; ISO:RGD.
DR   GO; GO:0052642; F:lysophosphatidic acid phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008195; F:phosphatidate phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0042392; F:sphingosine-1-phosphate phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0006672; P:ceramide metabolic process; IDA:UniProtKB.
DR   GO; GO:0046839; P:phospholipid dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0006644; P:phospholipid metabolic process; IDA:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; ISS:UniProtKB.
DR   GO; GO:0006670; P:sphingosine metabolic process; IDA:UniProtKB.
DR   CDD; cd03384; PAP2_wunen; 1.
DR   Gene3D; 1.20.144.10; Phosphatidic acid phosphatase type 2/haloperoxidase; 1.
DR   InterPro; IPR036938; P_Acid_Pase_2/haloperoxi_sf.
DR   InterPro; IPR000326; P_Acid_Pase_2/haloperoxidase.
DR   InterPro; IPR043216; PA_PP_rel.
DR   PANTHER; PTHR10165; LIPID PHOSPHATE PHOSPHATASE; 1.
DR   PANTHER; PTHR10165:SF26; PHOSPHOLIPID PHOSPHATASE 1; 1.
DR   Pfam; PF01569; PAP2; 1.
DR   SMART; SM00014; acidPPc; 1.
DR   SUPFAM; SSF48317; Acid phosphatase/Vanadium-dependent haloperoxidase; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Glycoprotein; Hydrolase;
KW   Lipid metabolism; Membrane; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..282
FT                   /note="Phospholipid phosphatase 1"
FT                   /id="PRO_0000220908"
FT   TOPO_DOM        1..6
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q61469"
FT   TRANSMEM        7..27
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        28..53
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q61469"
FT   TRANSMEM        54..74
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        75..88
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q61469"
FT   TRANSMEM        89..109
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        110..164
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q61469"
FT   TRANSMEM        165..185
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        186..194
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q61469"
FT   TRANSMEM        195..215
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        216..229
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q61469"
FT   TRANSMEM        230..250
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        251..282
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q61469"
FT   REGION          120..128
FT                   /note="Phosphatase sequence motif I"
FT                   /evidence="ECO:0000250|UniProtKB:O34349"
FT   REGION          168..171
FT                   /note="Phosphatase sequence motif II"
FT                   /evidence="ECO:0000250|UniProtKB:O34349"
FT   REGION          216..227
FT                   /note="Phosphatase sequence motif III"
FT                   /evidence="ECO:0000250|UniProtKB:O34349"
FT   REGION          257..282
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           5..7
FT                   /note="PDZ-binding; involved in localization to the apical
FT                   cell membrane"
FT                   /evidence="ECO:0000250|UniProtKB:O14494"
FT   ACT_SITE        171
FT                   /note="Proton donors"
FT                   /evidence="ECO:0000250|UniProtKB:O34349"
FT   ACT_SITE        223
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250|UniProtKB:O34349"
FT   SITE            227
FT                   /note="Stabilizes the active site histidine for
FT                   nucleophilic attack"
FT                   /evidence="ECO:0000250|UniProtKB:O34349"
FT   CARBOHYD        142
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         21..70
FT                   /note="GLPFIILTSRHTPFQRGVFCTDESIKYPYREDTIPYALLGGIVIPFCIIV
FT                   -> SMPMAVVNLGQIYPFQRGFFCSDNSVKYPYHDSTVTTSVLVLVGLGIPIFS (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11704545"
FT                   /id="VSP_009653"
SQ   SEQUENCE   282 AA;  31996 MW;  A4ED3DEB33FD7943 CRC64;
     MFDKPRLPYV VLDVICVLLA GLPFIILTSR HTPFQRGVFC TDESIKYPYR EDTIPYALLG
     GIVIPFCIIV MITGETLSVY FNVLHSNSFV SNHYIATIYK AVGAFLFGAS ASQSLTDIAK
     YSIGRLRPHF LAVCNPDWSK INCSDGYIEN FVCQGNEQKV REGRLSFYSG HSSFSMYCML
     FVALYLQARM KGDWARLLRP MLQFGLVALS IYVGLSRVSD YKHHWSDVLI GLIQGAVVAI
     LVVLYVTDFF KTTESNKERK EDSHTTLHET TNRQSYARNH EP
//
